← Leaderboards
Steven Reed
Xtem Pharmaceuticals, Inc.
$149,999
Attributed
$149,999
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$149,999 · 1
By mechanism
R43$149,999 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseAnimalsApoptosisAutomobile DrivingBcr-Abl Fusion ProteinsBcr-Abl Tyrosine KinaseBindingBody Weight DecreasedBone MarrowCell CompartmentationCellsCell TransplantationCell TransplantsChromosomal TranslocationChronicChronic Myeloid LeukemiaChronic Myeloid Leukemia CellChronic PhaseChronic-Phase Myeloid LeukemiaClinical ApplicationC-Myc GenesCohortConventional TherapyAcute